Luciana Mucci received M.D. degree cum laude from “G. d'Annunzio” University of Chieti.
She attended a residency program in Internal Medicine at Catholic University of Rome and received her Philosophy Doctor in Clinical Pharmacology at Department of Pharmacology of the same University.
She spent her post-doctoral research fellowship at the Clinical Trial Service Unit & Epidemiological Studies Unit of Nuffield Department of Population Health of Oxford University.
She worked as Internal Medicine consultant at “A. Gemelli” University Hospital, Department of Medical Sciences, Catholic University and at Fatebenefratelli Hospital of Isola Tiberina, Cardiology Department and Coronary Intensive Care Unit, both in Rome.
At present Dr. Mucci is working at the Italian Medicines Agency (AIFA), Economic Strategy of Pharmaceutical Products Department and Health Technology Assessment Area in Rome.
Her work and expertise is particularly focused on scientific support to development, regulatory and approval of specific drugs acting on diseases affecting cardiovascular and respiratory system, circulation, blood and hemostasis, and of anti-infective drugs.
She has participated in clinical and laboratory multi-center studies of which the results are published in peer reviewed journals.
Her main research interests involve the study of pathophysiology and pharmacology of eicosanoids and their altered generation in disease states associated with inflammation, such as different clinical setting at increased cardiovascular risk, cardiac fibrosis, cell proliferation and cancer.
Dr. Mucci’s scientific works include publications in peer reviewed journals as Blood, Arteriosclerosis, Thrombosis, and Vascular Biology, Journal of Thrombosis and Haemostasis, Internal and Emergency Medicine.
She acts as reviewer for scientific peer reviewed journals, including BMJ, Pharmacolagical Research and Frontiers.
She is Associate Member of the Editorial Board of “Frontiers Inflammation Pharmacology".
Address: Italian Medicines Agency
Economic Strategy of Pharmaceutical Products Department
Health Technology Assessment Area
Via del Tritone, 181 - 00187 Roma, Italy
Phone: +39-06-5978-4238;
Mobile Phone: +39-329-8663317
e-mail:
[email protected] –
[email protected]
Bewertung hinterlassen